| Mon, Nov 23, 2009 | | | Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for Early Responders to Company's BPH Drug NX-1207 GlobeNewswire (Mon, Nov 23)
| | Fri, Nov 13, 2009 | | | Nymox Reports Third Quarter 2009 Financial Results GlobeNewswire (Fri, Nov 13)
| | | Piper Jaffray Senior Research Analyst Sees M&A Activity As Brisk As Foreign Companies Seek US Specialty Pharmaceutical Distribution Networks Wall Street Transcript (Fri, Nov 13)
| | Wed, Oct 14, 2009 | | | Nymox's NX-1207 to be Clinically Tested for Prostate Cancer GlobeNewswire (Wed, Oct 14)
| | Mon, Oct 5, 2009 | | | Nymox Announces New Pooled Analysis Confirms 12 Month Benefit of NX-1207 Treatment for BPH GlobeNewswire (Mon, Oct 5)
| | Wed, Aug 26, 2009 | | | Nymox's NX-1207 Shows Major Effect On Liver Cancer GlobeNewswire (Wed, Aug 26)
| | Fri, Aug 14, 2009 | | | Nymox Reports Second Quarter 2009 Financial Results GlobeNewswire (Fri, Aug 14)
| | Wed, Jun 24, 2009 | | | 9 Stocks to Shake the Market at Motley Fool (Wed, Jun 24)
| | Tue, Jun 2, 2009 | | | Nymox Announces Dosing of First Patient in Phase 3 Trial for NX-1207 for BPH GlobeNewswire (Tue, Jun 2)
| | Fri, May 15, 2009 | | | Nymox Reports First Quarter 2009 Financial Results GlobeNewswire (Fri, May 15)
| | Tue, May 5, 2009 | | | Nymox Announces Start of Second Phase 3 Trial for NX-1207 for BPH GlobeNewswire (Tue, May 5)
| | Tue, Apr 21, 2009 | | | Nymox Reports Initiation of Phase 3 Trials for NX-1207 for BPH GlobeNewswire (Tue, Apr 21)
| | Fri, Mar 20, 2009 | | | NYMOX PHARMACEUTICAL CORP Financials EDGAR Online Financials (Fri, Mar 20)
| | Fri, Mar 13, 2009 | | | Nymox Reports 2008 Financial Results GlobeNewswire (Fri, Mar 13)
| | Tue, Feb 24, 2009 | | | Nymox Announces New Positive Results At 5 Years After Single Treatment in Long Term Study of NX-1207 for Benign Prostatic Hyperplasia GlobeNewswire (Tue, Feb 24)
| | Wed, Feb 18, 2009 | | | Nymox Provides Update On Pivotal Phase 3 Trials for BPH Drug GlobeNewswire (Wed, Feb 18)
| | Tue, Jan 13, 2009 | | | Nymox Releases Positive New Clinical Trial Data On Durability of Response Rates to Company's BPH Drug NX-1207 GlobeNewswire (Tue, Jan 13)
| | Thu, Jan 8, 2009 | | | Third Hand Smoke Recognized as Health Hazard GlobeNewswire (Thu, Jan 8)
| | Tue, Dec 30, 2008 | | | Nymox Announces $15 Million Equity Financing Commitment GlobeNewswire (Tue, Dec 30)
| | Fri, Dec 19, 2008 | | | Nymox NX-1207 Successful Clinical Trial Results Featured in Urology Times GlobeNewswire (Fri, Dec 19)
| Add NYMX News to My Yahoo!:

| |
|